A retrospective study of incidence rates of outcomes of interest in infants aged 1 month to < 1 year (Cohort 1) and patients aged 1 to < 2 years (Cohort 2) who were treated with IV PPS
Latest Information Update: 28 Sep 2022
At a glance
- Drugs Pantoprazole (Primary)
- Indications Erosive oesophagitis; Gastro-oesophageal reflux
- Focus Adverse reactions
- 28 Sep 2022 New trial record
- 28 Aug 2022 Results presented at the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management